South Korea · Delayed Price · Currency is KRW Englewood Lab Statistics
Total Valuation
Englewood Lab has a market cap or net worth of KRW 171.26 billion. The enterprise value is 133.45 billion.
| Market Cap | 171.26B |
| Enterprise Value | 133.45B |
Important Dates
The next estimated earnings date is Friday, November 6, 2026.
| Earnings Date | Nov 6, 2026 |
| Ex-Dividend Date | Dec 29, 2025 |
Share Statistics
Englewood Lab has 19.87 million shares outstanding.
| Current Share Class | 19.87M |
| Shares Outstanding | 19.87M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 5.74% |
| Owned by Institutions (%) | n/a |
| Float | 3.48M |
Valuation Ratios
The trailing PE ratio is 5.28.
| PE Ratio | 5.28 |
| Forward PE | n/a |
| PS Ratio | 0.78 |
| PB Ratio | 0.95 |
| P/TBV Ratio | 0.95 |
| P/FCF Ratio | 5.75 |
| P/OCF Ratio | 4.71 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.13, with an EV/FCF ratio of 4.48.
| EV / Earnings | 4.12 |
| EV / Sales | 0.61 |
| EV / EBITDA | 3.13 |
| EV / EBIT | 3.61 |
| EV / FCF | 4.48 |
Financial Position
The company has a current ratio of 4.37, with a Debt / Equity ratio of 0.12.
| Current Ratio | 4.37 |
| Quick Ratio | 3.34 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 0.50 |
| Debt / FCF | 0.72 |
| Interest Coverage | 35.78 |
Financial Efficiency
Return on equity (ROE) is 20.18% and return on invested capital (ROIC) is 18.56%.
| Return on Equity (ROE) | 20.18% |
| Return on Assets (ROA) | 10.27% |
| Return on Invested Capital (ROIC) | 18.56% |
| Return on Capital Employed (ROCE) | 18.98% |
| Weighted Average Cost of Capital (WACC) | 5.47% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.97 |
| Inventory Turnover | 3.74 |
Taxes
In the past 12 months, Englewood Lab has paid 13.10 billion in taxes.
| Income Tax | 13.10B |
| Effective Tax Rate | 28.77% |
Stock Price Statistics
The stock price has decreased by -31.72% in the last 52 weeks. The beta is 0.27, so Englewood Lab's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | -31.72% |
| 50-Day Moving Average | 8,543.60 |
| 200-Day Moving Average | 10,877.30 |
| Relative Strength Index (RSI) | 49.51 |
| Average Volume (20 Days) | 64,115 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Englewood Lab had revenue of KRW 218.19 billion and earned 32.43 billion in profits. Earnings per share was 1,632.15.
| Revenue | 218.19B |
| Gross Profit | 60.52B |
| Operating Income | 36.94B |
| Pretax Income | 45.53B |
| Net Income | 32.43B |
| EBITDA | 42.62B |
| EBIT | 36.94B |
| Earnings Per Share (EPS) | 1,632.15 |
Balance Sheet
The company has 59.21 billion in cash and 21.40 billion in debt, with a net cash position of 37.81 billion or 1,903.25 per share.
| Cash & Cash Equivalents | 59.21B |
| Total Debt | 21.40B |
| Net Cash | 37.81B |
| Net Cash Per Share | 1,903.25 |
| Equity (Book Value) | 180.90B |
| Book Value Per Share | 9,105.24 |
| Working Capital | 143.76B |
Cash Flow
In the last 12 months, operating cash flow was 36.38 billion and capital expenditures -6.58 billion, giving a free cash flow of 29.80 billion.
| Operating Cash Flow | 36.38B |
| Capital Expenditures | -6.58B |
| Depreciation & Amortization | 5.68B |
| Net Borrowing | -6.14B |
| Free Cash Flow | 29.80B |
| FCF Per Share | 1,500.12 |
Margins
Gross margin is 27.74%, with operating and profit margins of 16.93% and 14.86%.
| Gross Margin | 27.74% |
| Operating Margin | 16.93% |
| Pretax Margin | 20.87% |
| Profit Margin | 14.86% |
| EBITDA Margin | 19.54% |
| EBIT Margin | 16.93% |
| FCF Margin | 13.66% |
Dividends & Yields
This stock pays an annual dividend of 201.00, which amounts to a dividend yield of 2.37%.
| Dividend Per Share | 201.00 |
| Dividend Yield | 2.37% |
| Dividend Growth (YoY) | 95.35% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 13.65% |
| Buyback Yield | n/a |
| Shareholder Yield | 2.37% |
| Earnings Yield | 18.93% |
| FCF Yield | 17.40% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Englewood Lab has an Altman Z-Score of 5.35 and a Piotroski F-Score of 8.
| Altman Z-Score | 5.35 |
| Piotroski F-Score | 8 |